Personalized Medicine and the Contradictions and Limits of First-Generation Deescalation Trials in Patients With Human Papillomavirus-Positive Oropharyngeal Cancer.

Related Articles

Personalized Medicine and the Contradictions and Limits of First-Generation Deescalation Trials in Patients With Human Papillomavirus-Positive Oropharyngeal Cancer.

JAMA Otolaryngol Head Neck Surg. 2017 Nov 22;:

Authors: Orlandi E, Licitra L

PMID: 29167895 [PubMed - as supplied by publisher]

http://ift.tt/2BnasZE